AUPH
Price
$15.21
Change
-$0.33 (-2.12%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
2.05B
111 days until earnings call
Intraday BUY SELL Signals
MLTX
Price
$12.57
Change
-$0.20 (-1.57%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
904.72M
105 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AUPH vs MLTX

Header iconAUPH vs MLTX Comparison
Open Charts AUPH vs MLTXBanner chart's image
Aurinia Pharmaceuticals
Price$15.21
Change-$0.33 (-2.12%)
Volume$46.46K
Capitalization2.05B
MoonLake Immunotherapeutics
Price$12.57
Change-$0.20 (-1.57%)
Volume$68.19K
Capitalization904.72M
AUPH vs MLTX Comparison Chart in %
AUPH
Daily Signal:
Gain/Loss:
MLTX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AUPH vs. MLTX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AUPH is a Buy and MLTX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (AUPH: $15.54 vs. MLTX: $12.77)
Brand notoriety: AUPH and MLTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AUPH: 97% vs. MLTX: 53%
Market capitalization -- AUPH: $2.05B vs. MLTX: $904.72M
AUPH [@Biotechnology] is valued at $2.05B. MLTX’s [@Biotechnology] market capitalization is $904.72M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AUPH’s FA Score shows that 0 FA rating(s) are green whileMLTX’s FA Score has 1 green FA rating(s).

  • AUPH’s FA Score: 0 green, 5 red.
  • MLTX’s FA Score: 1 green, 4 red.
According to our system of comparison, AUPH is a better buy in the long-term than MLTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AUPH’s TA Score shows that 6 TA indicator(s) are bullish while MLTX’s TA Score has 4 bullish TA indicator(s).

  • AUPH’s TA Score: 6 bullish, 4 bearish.
  • MLTX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, AUPH is a better buy in the short-term than MLTX.

Price Growth

AUPH (@Biotechnology) experienced а +7.54% price change this week, while MLTX (@Biotechnology) price change was +20.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

AUPH is expected to report earnings on Mar 04, 2026.

MLTX is expected to report earnings on Feb 26, 2026.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AUPH($2.05B) has a higher market cap than MLTX($905M). AUPH YTD gains are higher at: 73.051 vs. MLTX (-76.417). AUPH has higher annual earnings (EBITDA): 86.5M vs. MLTX (-196.98M). MLTX has more cash in the bank: 425M vs. AUPH (315M). MLTX has less debt than AUPH: MLTX (75.8M) vs AUPH (81.8M). AUPH has higher revenues than MLTX: AUPH (260M) vs MLTX (0).
AUPHMLTXAUPH / MLTX
Capitalization2.05B905M226%
EBITDA86.5M-196.98M-44%
Gain YTD73.051-76.417-96%
P/E Ratio27.75N/A-
Revenue260M0-
Total Cash315M425M74%
Total Debt81.8M75.8M108%
FUNDAMENTALS RATINGS
AUPH: Fundamental Ratings
AUPH
OUTLOOK RATING
1..100
28
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
99
SMR RATING
1..100
49
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AUPHMLTX
RSI
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
56%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
69%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
68%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 22 days ago
82%
Bearish Trend 28 days ago
72%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
75%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
AUPH
Daily Signal:
Gain/Loss:
MLTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PARMX42.460.17
+0.40%
Parnassus Mid-Cap
FNRCX43.91N/A
N/A
Fidelity Advisor Energy C
NCAVX12.30N/A
N/A
Nuance Concentrated Value Investor
FNILX24.64N/A
N/A
Fidelity ZERO Large Cap Index
IJSSX14.13-0.01
-0.07%
VY® JPMorgan Small Cap Core Equity S

AUPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, AUPH has been loosely correlated with JSPR. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if AUPH jumps, then JSPR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AUPH
1D Price
Change %
AUPH100%
-0.89%
JSPR - AUPH
44%
Loosely correlated
+4.12%
MLTX - AUPH
40%
Loosely correlated
+8.68%
VCYT - AUPH
39%
Loosely correlated
-0.84%
FOLD - AUPH
38%
Loosely correlated
+1.07%
KALA - AUPH
37%
Loosely correlated
-2.55%
More

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been closely correlated with KALA. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if MLTX jumps, then KALA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
+8.68%
KALA - MLTX
88%
Closely correlated
-2.55%
IOBT - MLTX
75%
Closely correlated
-6.00%
NEVPF - MLTX
70%
Closely correlated
N/A
XNCR - MLTX
50%
Loosely correlated
-3.23%
NUVL - MLTX
48%
Loosely correlated
+0.91%
More